Skip to main navigation Skip to search Skip to main content

Partial response of a rare malignant metastatic diffuse tenosynovial giant cell tumor with benign histologic features, treated with SCH 717-454, an insulin growth factor receptor inhibitor, in combination with everolimus, an MTOR inhibitor

  • Swati Sikaria
  • , Josefine Heim-Hall
  • , Elizabeth H. Diaz
  • , Ronald Williams
  • , Kamelesh Sankhala
  • , Brenda Laabs
  • , Monica Mita

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Partial response of a rare malignant metastatic diffuse tenosynovial giant cell tumor with benign histologic features, treated with SCH 717-454, an insulin growth factor receptor inhibitor, in combination with everolimus, an MTOR inhibitor'. Together they form a unique fingerprint.
Sort by